VitaNova Life Sciences Reports 130% Revenue Growth but Faces Net Loss in Latest Quarter

VitaNova Life Sciences Corporation, formerly known as Yijia Group Corp., reported significant financial changes in its latest 10-Q filing for the three and nine months ended January 31, 2026. The company generated revenues of $709,625 for the third quarter, a 130% increase from $308,318 in the same period last year. For the nine months, revenues rose to $1,240,639, up 75% from $708,913 in the prior year. The increase is attributed primarily to the launch of its dietary supplement products segment, which accounted for the majority of revenue growth.

Despite the revenue increase, the company reported a net loss of $44,362 for the third quarter, compared to a net income of $72,978 in the same quarter of the previous year. For the nine-month period, the net loss was $54,853, contrasting with a net income of $50,414 in the prior year. The losses were attributed to rising operating expenses, particularly in general and administrative costs, which surged by 616% to $219,601 in the third quarter, largely due to increased legal and professional fees.

Operationally, VitaNova's total current assets increased to $2,311,806 as of January 31, 2026, compared to $2,256,251 at the end of the previous fiscal year. Cash reserves also improved significantly, rising to $1,168,904 from $782,810. However, total current liabilities increased to $457,975 from $347,567, primarily due to higher income tax payable and accrued expenses. The company’s accounts receivable decreased to $1,004,442 from $1,266,951, indicating improved cash flow management.

In terms of strategic developments, the company underwent a name change and a 1-for-3 reverse stock split effective January 27, 2026, aimed at enhancing its market presence. Additionally, on March 2026, VitaNova established a new wholly-owned subsidiary, VitaNova Global Foods Corporation, to further expand its business operations. The company continues to explore opportunities to enhance profitability and market share in the dietary supplement sector.

Looking ahead, VitaNova's management remains cautious but optimistic about future growth, emphasizing the potential of its dietary supplement products. The company is focused on strengthening its operational efficiencies and financial reporting processes to address identified weaknesses in internal controls. While the outlook remains uncertain due to market conditions, management is committed to implementing measures to improve financial performance and shareholder value in the upcoming quarters.